Italian Economic Journal

, Volume 5, Issue 3, pp 455–472 | Cite as

Vaccination as a trade-off between risks

  • David Crainich
  • Louis Eeckhoudt
  • Mario MenegattiEmail author
Research Paper


While it reduces the probability of facing a primary (or vaccine-preventable) disease, vaccination may also introduce the risk of facing vaccine induced side effects. In this paper, we address the link between this feature of vaccination and attitudes toward risk. Risk aversion is shown to increase the propensity to vaccinate when the primary disease is lethal or when the risks of primary disease and of side effects are faced in different periods. When the primary disease is non-lethal and may occur together with side effects, we show how the effect of risk aversion is affected by the probability and severity of each disease. The implications of the introduction of random effects of primary disease and of random side effects are also analyzed.


Vaccination Self-protection Risk substitution Risk aversion 

JEL Classification

D81 I10 



  1. Basch CH, Zybert P, Reeves R, Basch CE (2017) What do popular YouTube™ videos say about vaccines? Child Care Health Dev 43(4):499–503CrossRefGoogle Scholar
  2. Blaisdell LL, Gutheil C, Hootsmans NAM, Han PKJ (2016) Unknown risks: parental hesitation about vaccination. Med Dec Mak 36:479–489CrossRefGoogle Scholar
  3. Bleichrodt H, Crainich D, Eeckhoudt L (2003) The effect of comorbidities on treatment decisions. J Health Econ 22:805–820CrossRefGoogle Scholar
  4. Brianti M, Menegatti M, Magnani M (2017) “Optimal choice of prevention and cure under uncertainty on disease effect and cure effectiveness. Res Econ. CrossRefGoogle Scholar
  5. Brito D, Sheshinski E, Intriligator M (1991) Externalities and compulsory vaccinations. J Public Econ 45:69–90CrossRefGoogle Scholar
  6. Courbage C, Rey B (2006) Prudence and optimal prevention for health risks. Health Econ 15:1323–1327CrossRefGoogle Scholar
  7. Courbage C, Rey B (2016) Decision thresholds and changes in risk for preventive treatment. Health Econ 25:111–124CrossRefGoogle Scholar
  8. Ehrlich I, Becker G (1972) Market insurance, self-insurance, and self-protection. J Polit Econ 80:623–648CrossRefGoogle Scholar
  9. Fabry P, Gagneur A, Pasquier JC (2011) Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Vaccine 29(9):1824–1829CrossRefGoogle Scholar
  10. Fadda M, Allam A, Schultz PJ (2015) Arguments and sources on Italian online forums on childhood vaccinations: results of a content. Vaccine 33:7152–7159CrossRefGoogle Scholar
  11. Felder S, Mayrhofer T (2014) Risk preferences: consequences for test and treatment thresholds and optimal cutoffs. Med Decis Mak 34:33–41CrossRefGoogle Scholar
  12. Freimuth VS, Jamison A, Hancock G, Musa D, Hilyard K, Crouse Quinn S (2017) The role of risk perception in flu vaccine behavior among African-American and white adults in the United States. Risk Anal. CrossRefGoogle Scholar
  13. Gargano LM, Painter JE, Sales JM, Morfaw C, Jones LM, Murray D et al (2011) Seasonal and 2009 H1N1 influenza vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination among secondary school teachers and staff. Hum Vaccine 7(1):89–95CrossRefGoogle Scholar
  14. Gaygisiz U, Gaygisiz E, Ozkan T, Lajunen T (2010) Why were Turks unwilling to accept the A/H1N1 influenzapandemic vaccination? People’s beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic. Vaccine 29:329–333CrossRefGoogle Scholar
  15. Geoffard P-Y, Philippson T (1997) Disease eradication: private versus public vaccination. Am Econ Rev 87:222–230Google Scholar
  16. Lawler EC (2017) Effectiveness of vaccination recommendations versus mandates: evidence from the hepatitis a vaccine. J Health Econ 52:45–62CrossRefGoogle Scholar
  17. Liu D, Menegatti M (2019) Optimal saving and health prevention. J Econ. CrossRefGoogle Scholar
  18. Liu L, Rettenmaier AJ, Saving TR (2009) Conditional payment and self-protection. J Risk Uncertainty 38:159–172CrossRefGoogle Scholar
  19. Maurer J (2015) Inspecting the mechanism: a longitudinal analysis of socioeconomic status differences in perceived influenza risks, vaccination intentions, and vaccination behaviors during the 2009–2010 Influenza Pandemic. Med Decis Mak 36:887–899CrossRefGoogle Scholar
  20. Menegatti M (2009) Optimal prevention and prudence in a two period model. Math Soc Sci 58:393–397CrossRefGoogle Scholar
  21. Menegatti M (2014) Optimal choice on prevention and cure: a new economic analysis. Eur J Health Econ 15:363–372CrossRefGoogle Scholar
  22. Murphy TV, Gargiullo PM, Massoudi MS et al (2001) Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 364:564–572CrossRefGoogle Scholar
  23. Myers LB, Goodwin R (2011) Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health 11(15):1–8Google Scholar
  24. Nuscheler R, Roder K (2016) To vaccinate or to procrastinate? That is the prevention question. Health Econ 25:1560–1581CrossRefGoogle Scholar
  25. Patel MM, Richardson Lopez-Collada V, Mattos Bulhoes M et al (2011) Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 364:2283–2292CrossRefGoogle Scholar
  26. Pauker SG, Kassirer JP (1975) Therapeutic decision making: a cost-benefit analysis. N Engl J Med 293:229–234CrossRefGoogle Scholar
  27. Rainey JJ, Watkins M, Ryman TK, Sandhu P, Bo A, Banerjee K (2011) Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999–2009. Vaccine 29:8215–8221CrossRefGoogle Scholar
  28. Rheinberger CM, Herrera-Araujo D, Hammitt JK (2016) The value of disease prevention vs treatment. J Health Econ 50:247–255CrossRefGoogle Scholar
  29. Smith LE, Webster RK, Weinman J, Amlôt R, Yiend J, Rubin GJ (2017) Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: a cross-sectional survey in England. Vaccine 35:1936–1945CrossRefGoogle Scholar
  30. Thompson EL, Rosen BL, Vamos CA, Kadono M, Daley EM (2017) Human papillomavirus vaccination: what are the reasons for nonvaccination among US adolescents? J Adolesc Health 61:288–293CrossRefGoogle Scholar
  31. Tsuchiya Y, Shida N, Izumi S, Ogasawara M, Kakinuma W, Tsujiuchi T, Machida K (2016) Factors associated with mothers not vaccinating their children against mumps in Japan. Public Health 137:95–105CrossRefGoogle Scholar
  32. World Health Organization (2017) Report of the World Health assembly global vaccine action plan. World Health Organization, GenevaGoogle Scholar
  33. Yaari ME (1987) The dual theory of choice under risk. Econometrica 55:95–115CrossRefGoogle Scholar

Copyright information

© Società Italiana degli Economisti (Italian Economic Association) 2019

Authors and Affiliations

  1. 1.IÉSEG School of ManagementCNRS (LEM, UMR 9221)LilleFrance
  2. 2.IÉSEG School of ManagementLEM (UMR 9221)LilleFrance
  3. 3.Dipartimento di Scienze Economiche e AziendaliUniversità di ParmaParmaItaly

Personalised recommendations